Gerresheimer at Pharmapack 2024: Innovative solutions and expert presentations
Broad portfolio for biologics, including cell and gene therapy products Digitally connected Drug Delivery Devices for s…
Broad portfolio for biologics, including cell and gene therapy products Digitally connected Drug Delivery Devices for s…
Breites Portfolio für Biologika, einschließlich Zell- und Gentherapieprodukte Digital vernetzte Drug Delivery Devices…
BSI Life Sciences today announced biopharma Ocular Therapeutix (NASDAQ: OCUL) as its latest client to go live with its c…
Research collaboration leverages bit.bio’s machine learning-powered discovery platform to identify transcription factor…
Rune Labs’ StriveStudy platform and Emerald Innovations’ Emerald wireless monitoring sensor will passively capture data…
With innovative, solution-oriented, and sustainable developments, the Gerresheimer team presents itself at Pharmapack an…
Edmund Optics®, a leading global manufacturer and supplier of optical components, announces the recipients of its 2022 E…
With DropControl, Gerresheimer has developed a new dropper insert for modern drugs with low viscosity for ophthalmology,…
On August 27, Gerresheimer Boleslawiec S.A. celebrates its 70th anniversary in Poland. Founded in 1952, the industrial p…
The global medical laser market size is expected to be worth around US$ 15.63 billion by 2030 and is poised to record a…